Discover Novel Biomarkers for Drug Discovery and Clinical Diagnostics

Developed for performance in human serum and plasma, the SomaScan Assay v4.1 can measure approximately 7,000 unique human protein analytes in small volumes of biological samples. 

This assay, when paired with the SomaScan Platform, can assist with the discovery of novel biomarkers during drug discovery, pre-clinical and clinical drug development, and for the development of clinical diagnostics across a wide range of clinically important diseases.

Download this app note to learn how this platform can:

• Offer advantages over other biomarker platforms in sample size, cost, time and multiplexing capability
• Measure analytes spanning a range of 10 logs in human plasma or serum with excellent reproducibility
• Provide information on current status and future trajectory for virtually every disease or condition of interest